Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Autoimmune Disorders

  Free Subscription


Articles published in Kidney Int

Retrieve available abstracts of 85 articles:
HTML format
Text format



Single Articles


    June 2018
  1. ARKATKAR T, Jacobs HM, Du SW, Li QZ, et al
    TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.
    Kidney Int. 2018 Jun 12. pii: S0085-2538(18)30252.
    PubMed     Text format     Abstract available


    May 2018
  2. SAHA MK, Julian BA, Novak J, Rizk DV, et al
    Secondary IgA nephropathy.
    Kidney Int. 2018 May 24. pii: S0085-2538(18)30245.
    PubMed     Text format     Abstract available


  3. ZHU L, Guo WY, Shi SF, Liu LJ, et al
    Circulating complement factor H-related protein 5 levels contribute to development and progression of IgA nephropathy.
    Kidney Int. 2018 May 11. pii: S0085-2538(18)30214.
    PubMed     Text format     Abstract available


  4. GUMBER R, Cohen JB, Palmer MB, Kobrin SM, et al
    A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits.
    Kidney Int. 2018 May 11. pii: S0085-2538(18)30211.
    PubMed     Text format     Abstract available


  5. LIM CC, Choo JCJ, Chan CM, Woo KT, et al
    Age-adjusted global glomerulosclerosis in addition to Oxford histological classification of IgA nephropathy.
    Kidney Int. 2018;93:1250.
    PubMed     Text format    


    April 2018
  6. SAID SM, Cosio FG, Valeri AM, Leung N, et al
    Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograft.
    Kidney Int. 2018 Apr 28. pii: S0085-2538(18)30175.
    PubMed     Text format     Abstract available


  7. ELLER K, Rosenkranz AR
    Atypical chemokine receptors-"chemokine PACMANs" as new therapeutic targets in glomerulonephritis.
    Kidney Int. 2018;93:774-775.
    PubMed     Text format     Abstract available



  8. Fu J, Wang Z, Lee K, et al. Transcriptomic analysis uncovers novel synergistic mechanisms in combination therapy for lupus nephritis. Kidney Int. 2018;93:416-429.
    Kidney Int. 2018;93:1018.
    PubMed     Text format    


  9. VAN DE LOGT AE, Dahan K, Rousseau A, van der Molen R, et al
    Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab.
    Kidney Int. 2018;93:1016-1017.
    PubMed     Text format    


    March 2018
  10. FLOEGE J
    IgA nephropathy: toward more specific diagnosis (and rescue of snails).
    Kidney Int. 2018;93:542-544.
    PubMed     Text format     Abstract available


    February 2018
  11. BAJEMA IM, Wilhelmus S, Alpers CE, Bruijn JA, et al
    Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices.
    Kidney Int. 2018 Feb 16. pii: S0085-2538(17)30859.
    PubMed     Text format     Abstract available


  12. MOON JS, Mun CH, Kim JH, Cho JY, et al
    Intranuclear delivery of the transcription modulation domain of Tbet-improved lupus nephritis in (NZB/NZW) F1 lupus-prone mice.
    Kidney Int. 2018 Feb 3. pii: S0085-2538(17)30853.
    PubMed     Text format     Abstract available


    January 2018
  13. BIDEAK A, Blaut A, Hoppe JM, Muller MB, et al
    The atypical chemokine receptor 2 limits renal inflammation and fibrosis in murine progressive immune complex glomerulonephritis.
    Kidney Int. 2018 Jan 22. pii: S0085-2538(17)30829.
    PubMed     Text format     Abstract available


  14. SUZUKI H, Yasutake J, Makita Y, Tanbo Y, et al
    IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
    Kidney Int. 2018 Jan 9. pii: S0085-2538(17)30799.
    PubMed     Text format     Abstract available


  15. BOMBACK AS, Santoriello D, Avasare RS, Regunathan-Shenk R, et al
    C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.
    Kidney Int. 2018 Jan 6. pii: S0085-2538(17)30802.
    PubMed     Text format     Abstract available


    December 2017
  16. EYMAEL J, Sharma S, Loeven MA, Wetzels JF, et al
    CD44 is required for the pathogenesis of experimental crescentic glomerulonephritis and collapsing focal segmental glomerulosclerosis.
    Kidney Int. 2017 Dec 21. pii: S0085-2538(17)30770.
    PubMed     Text format     Abstract available


  17. DICK J, Gan PY, Ford SL, Odobasic D, et al
    C5a receptor 1 promotes autoimmunity, neutrophil dysfunction and injury in experimental anti-myeloperoxidase glomerulonephritis.
    Kidney Int. 2017 Dec 11. pii: S0085-2538(17)30768.
    PubMed     Text format     Abstract available


    November 2017
  18. AMANN K
    Do ANCAs make the difference in lupus nephritis?
    Kidney Int. 2017;92:1048-1050.
    PubMed     Text format     Abstract available


  19. FU J, Wang Z, Lee K, Wei C, et al
    Transcriptomic analysis uncovers novel synergistic mechanisms in combination therapy for lupus nephritis.
    Kidney Int. 2017 Nov 1. pii: S0085-2538(17)30671.
    PubMed     Text format     Abstract available


    October 2017
  20. THURMAN JM, Laskowski J
    Complement factor H-related proteins in IgA nephropathy-sometimes a gentle nudge does the trick.
    Kidney Int. 2017;92:790-793.
    PubMed     Text format     Abstract available


    September 2017
  21. SINGH G, Bhardwaj S, Singh L, Sinha A, et al
    Proliferative glomerulonephritis with monotypic IgA-kappa deposits in a 10-year-old.
    Kidney Int. 2017;92:765-766.
    PubMed     Text format    


    August 2017
  22. DE FIJTER JW
    Recurrence of glomerulonephritis: an underestimated and unmet medical need.
    Kidney Int. 2017;92:294-296.
    PubMed     Text format     Abstract available


  23. FLOEGE J
    Mucosal corticosteroid therapy of IgA nephropathy.
    Kidney Int. 2017;92:278-280.
    PubMed     Text format     Abstract available


    July 2017
  24. DAI Y, Chen A, Liu R, Gu L, et al
    Retinoic acid improves nephrotoxic serum-induced glomerulonephritis through activation of podocyte retinoic acid receptor alpha.
    Kidney Int. 2017 Jul 27. pii: S0085-2538(17)30321.
    PubMed     Text format     Abstract available


  25. BROCKLEBANK V, Johnson S, Sheerin TP, Marks SD, et al
    Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30323.
    PubMed     Text format     Abstract available


  26. TURNER-STOKES T, Wilson HR, Morreale M, Nunes A, et al
    Positive antineutrophil cytoplasmic antibody serology in patients with lupus nephritis is associated with distinct histopathologic features on renal biopsy.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30324.
    PubMed     Text format     Abstract available


  27. GALSGAARD J, Persson F, Hansen TW, Jorsal A, et al
    Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Kidney Int. 2017 Jul 13. pii: S0085-2538(17)30310.
    PubMed     Text format     Abstract available


  28. BOJIC M, Kozakowski N, Becede M, Kerschbaumer A, et al
    The Case | Myeloid bodies in the kidney biopsy of a patient with systemic lupus erythematosus.
    Kidney Int. 2017;92:271-272.
    PubMed     Text format    


    June 2017
  29. MEDJERAL-THOMAS NR, Lomax-Browne HJ, Beckwith H, Willicombe M, et al
    Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy.
    Kidney Int. 2017 Jun 30. pii: S0085-2538(17)30256.
    PubMed     Text format     Abstract available


  30. TORTAJADA A, Gutierrez E, Goicoechea de Jorge E, Anter J, et al
    Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy.
    Kidney Int. 2017 Jun 18. pii: S0085-2538(17)30254.
    PubMed     Text format     Abstract available


  31. ALLEN PJ, Chadban SJ, Craig JC, Lim WH, et al
    Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes.
    Kidney Int. 2017 Jun 7. pii: S0085-2538(17)30208.
    PubMed     Text format     Abstract available


  32. VAN LAECKE S, Van Biesen W
    Severe hypertension with renal thrombotic microangiopathy: what happened to the usual suspect?
    Kidney Int. 2017;91:1271-1274.
    PubMed     Text format     Abstract available


    May 2017
  33. GUL A, Harford A, Zager P
    Mendelian randomization to establish the causality of uric acid with diabetic nephropathy in type 1 diabetics.
    Kidney Int. 2017;91:1005-1007.
    PubMed     Text format     Abstract available


    April 2017
  34. YAMANOUCHI M, Skupien J, Niewczas MA, Smiles AM, et al
    Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.
    Kidney Int. 2017 Apr 7. pii: S0085-2538(17)30112.
    PubMed     Text format     Abstract available


    March 2017
  35. KROLEWSKI AS, Skupien J, Rossing P, Warram JH, et al
    Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes.
    Kidney Int. 2017 Mar 30. pii: S0085-2538(17)30081.
    PubMed     Text format     Abstract available


  36. TRIMARCHI H, Barratt J, Cattran DC, Cook HT, et al
    Oxford Classification of IgA nephropathy 2016-the role of crescentic lesions: an update from the IgA Nephropathy Classification Working Group.
    Kidney Int. 2017 Mar 21. pii: S0085-2538(17)30101.
    PubMed     Text format     Abstract available


  37. ROSENZWAJG M, Languille E, Debiec H, Hygino J, et al
    B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab.
    Kidney Int. 2017 Mar 15. pii: S0085-2538(17)30039.
    PubMed     Text format     Abstract available


  38. VIGNON M, Cohen C, Faguer S, Noel LH, et al
    The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits.
    Kidney Int. 2017;91:720-728.
    PubMed     Text format     Abstract available


  39. HE X, Cheng R, Park K, Benyajati S, et al
    Pigment epithelium-derived factor, a noninhibitory serine protease inhibitor, is renoprotective by inhibiting the Wnt pathway.
    Kidney Int. 2017;91:642-657.
    PubMed     Text format     Abstract available


    February 2017
  40. AHOLA AJ, Sandholm N, Forsblom C, Harjutsalo V, et al
    The serum uric acid concentration is not causally linked to diabetic nephropathy in type 1 diabetes.
    Kidney Int. 2017 Feb 21. pii: S0085-2538(16)30757.
    PubMed     Text format     Abstract available


    January 2017
  41. KLEMIS V, Ghura H, Federico G, Wurfel C, et al
    Circulating fibronectin contributes to mesangial expansion in a murine model of type 1 diabetes.
    Kidney Int. 2017 Jan 31. pii: S0085-2538(16)30706.
    PubMed     Text format     Abstract available


  42. LUQUE Y, Cathelin D, Vandermeersch S, Xu X, et al
    Glomerular common gamma chain confers B- and T-cell-independent protection against glomerulonephritis.
    Kidney Int. 2017 Jan 19. pii: S0085-2538(16)30653.
    PubMed     Text format     Abstract available


  43. CATTRAN DC, Brenchley PE
    Membranous nephropathy: integrating basic science into improved clinical management.
    Kidney Int. 2017 Jan 5. pii: S0085-2538(16)30617.
    PubMed     Text format     Abstract available


    December 2016
  44. KIM CS, Bae EH, Ma SK, Kim SW, et al
    The Case | Seizure, ophthalmoplegia, and amnesia in a peritoneal dialysis patient.
    Kidney Int. 2016;90:1389-1390.
    PubMed     Text format    


    November 2016
  45. BELLUR SS, Lepeytre F, Vorobyeva O, Troyanov S, et al
    Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
    Kidney Int. 2016 Nov 30. pii: S0085-2538(16)30562.
    PubMed     Text format     Abstract available


  46. YAN JJ, Lee JG, Jang JY, Koo TY, et al
    IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4+CD25+Foxp3+ regulatory T cells.
    Kidney Int. 2016 Nov 30. pii: S0085-2538(16)30551.
    PubMed     Text format     Abstract available


  47. YOU H, Gao T, Raup-Konsavage WM, Cooper TK, et al
    Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
    Kidney Int. 2016 Nov 30. pii: S0085-2538(16)30598.
    PubMed     Text format     Abstract available


  48. COSIO FG, Cattran DC
    Recent advances in our understanding of recurrent primary glomerulonephritis after kidney transplantation.
    Kidney Int. 2016 Nov 9. pii: S0085-2538(16)30484.
    PubMed     Text format     Abstract available


    October 2016
  49. PANG Y, Tan Y, Li Y, Zhang J, et al
    Serum A08 C1q antibodies are associated with disease activity and prognosis in Chinese patients with lupus nephritis.
    Kidney Int. 2016 Oct 10. pii: S0085-2538(16)30437.
    PubMed     Text format     Abstract available


  50. CATTRAN DC
    Toward quantitating the burden of glomerulonephritis in the United States.
    Kidney Int. 2016;90:732-4.
    PubMed     Text format     Abstract available


    August 2016
  51. BIENAIME F, Legendre C, Terzi F, Canaud G, et al
    Antiphospholipid syndrome and kidney disease.
    Kidney Int. 2016 Aug 20. pii: S0085-2538(16)30317.
    PubMed     Text format     Abstract available


  52. LEVENTHAL JS, Ross MJ
    LAPping up dead cells to prevent lupus nephritis: a novel role for noncanonical autophagy in autoimmunity.
    Kidney Int. 2016;90:238-9.
    PubMed     Text format     Abstract available


    July 2016
  53. TAKASHIMA S, Fujita H, Fujishima H, Shimizu T, et al
    Stromal cell-derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy.
    Kidney Int. 2016 Jul 27. pii: S0085-2538(16)30273.
    PubMed     Text format     Abstract available


  54. WETMORE JB, Guo H, Liu J, Collins AJ, et al
    The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis.
    Kidney Int. 2016 Jul 14. pii: S0085-2538(16)30211.
    PubMed     Text format     Abstract available


  55. VANKALAKUNTI M, Vasavi B, Anitha A
    Intravascular large B-cell lymphoma: masquerade as membranoproliferative glomerulonephritis.
    Kidney Int. 2016;90:231-2.
    PubMed     Text format    


  56. ANDERS HJ, Rovin B
    A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis.
    Kidney Int. 2016 Jul 1. pii: S0085-2538(16)30208.
    PubMed     Text format     Abstract available


    June 2016
  57. HOOVER PJ, Costenbader KH
    Insights into the epidemiology and management of lupus nephritis from the US rheumatologist's perspective.
    Kidney Int. 2016 Jun 22. pii: S0085-2538(16)30171.
    PubMed     Text format     Abstract available


  58. RYAN MS, Satoskar AA, Nadasdy GM, Brodsky SV, et al
    Phospholipase A2 receptor staining is absent in many kidney biopsies with early-stage membranous glomerulonephritis.
    Kidney Int. 2016;89:1402-3.
    PubMed     Text format    


  59. RAMACHANDRAN R, Kumar V, Jha V
    Cyclical cyclophosphamide and steroids is effective in resistant or relapsing nephrotic syndrome due to M-type phospholipase A2 receptor-related membranous nephropathy after tacrolimus therapy.
    Kidney Int. 2016;89:1401-2.
    PubMed     Text format    


  60. GUERRY MJ, Vanhille P, Ronco P, Debiec H, et al
    Serum anti-PLA2R antibodies may be present before clinical manifestations of membranous nephropathy.
    Kidney Int. 2016;89:1399.
    PubMed     Text format    


    May 2016
  61. DRAGUN D, Catar R, Philippe A
    Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity.
    Kidney Int. 2016 May 14. pii: S0085-2538(16)30071.
    PubMed     Text format     Abstract available


  62. HOFSTRA JM, Wetzels JF
    Should aspirin be used for primary prevention of thrombotic events in patients with membranous nephropathy?
    Kidney Int. 2016;89:981-3.
    PubMed     Text format     Abstract available


    April 2016
  63. KLESSENS CQ, Woutman TD, Veraar KA, Zandbergen M, et al
    An autopsy study suggests that diabetic nephropathy is underdiagnosed.
    Kidney Int. 2016 Apr 9. pii: S0085-2538(16)00313.
    PubMed     Text format     Abstract available


  64. ZHANG L, Lee G, Liu X, Pascoe EM, et al
    Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.
    Kidney Int. 2016 Apr 8. pii: S0085-2538(16)00363.
    PubMed     Text format     Abstract available


  65. PICCOLI GB, Capobianco M, Vigotti FN, Naretto C, et al
    The Case | The young philosopher with multiple sclerosis and proteinuria.
    Kidney Int. 2016;89:961-3.
    PubMed     Text format    


  66. NEVES PD, Bezerra KS, Silveira MA, Yu L, et al
    Schistosoma mansoni and membranous nephropathy.
    Kidney Int. 2016;89:959.
    PubMed     Text format    


  67. ROSALES IA, Colvin RB
    Glomerular disease with idiopathic linear immunoglobulin deposition: a rose by any other name would be atypical.
    Kidney Int. 2016;89:750-2.
    PubMed     Text format     Abstract available


  68. NASR SH, Collins AB, Alexander MP, Schraith DF, et al
    The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis.
    Kidney Int. 2016;89:897-908.
    PubMed     Text format     Abstract available


    February 2016
  69. LEE T, Derebail VK, Kshirsagar AV, Chung Y, et al
    Patients with primary membranous nephropathy are at high risk of cardiovascular events.
    Kidney Int. 2016 Feb 26. pii: S0085-2538(16)00275.
    PubMed     Text format     Abstract available


  70. NOWAK N, Skupien J, Niewczas MA, Yamanouchi M, et al
    Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes.
    Kidney Int. 2016;89:459-67.
    PubMed     Text format     Abstract available


    January 2016
  71. PRUTHI R, McClure M, Casula A, Roderick PJ, et al
    Long-term graft outcomes and patient survival are lower posttransplant in patients with a primary renal diagnosis of glomerulonephritis.
    Kidney Int. 2016 Jan 21. pii: S0085-2538(15)00176.
    PubMed     Text format     Abstract available


  72. HOUSSIAU FA
    Moving East: the Euro-Lupus Nephritis regimen in Asia.
    Kidney Int. 2016;89:25-7.
    PubMed     Text format     Abstract available


  73. FLOEGE J
    Prognostic assessment of IgA nephropathy: how much does histology add?
    Kidney Int. 2016;89:19-21.
    PubMed     Text format     Abstract available


  74. FLOEGE J, Rauen T
    Immunosuppression in IgA nephropathy: how certain are we?
    Kidney Int. 2016;89:9-11.
    PubMed     Text format     Abstract available


  75. BARBOUR SJ, Espino-Hernandez G, Reich HN, Coppo R, et al
    The MEST score provides earlier risk prediction in lgA nephropathy.
    Kidney Int. 2016;89:167-75.
    PubMed     Text format     Abstract available


  76. KLUGER MA, Melderis S, Nosko A, Goerke B, et al
    Treg17 cells are programmed by Stat3 to suppress Th17 responses in systemic lupus.
    Kidney Int. 2016;89:158-66.
    PubMed     Text format     Abstract available


  77. IRIFUKU T, Doi S, Sasaki K, Doi T, et al
    Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression.
    Kidney Int. 2016;89:147-57.
    PubMed     Text format     Abstract available


  78. SELEZNIK G, Seeger H, Bauer J, Fu K, et al
    The lymphotoxin beta receptor is a potential therapeutic target in renal inflammation.
    Kidney Int. 2016;89:113-26.
    PubMed     Text format     Abstract available


    December 2015
  79. SETHI S, Fervenza FC, Smith RJ, Haas M, et al
    Overlap of ultrastructural findings in C3 glomerulonephritis and dense deposit disease.
    Kidney Int. 2015;88:1449-1450.
    PubMed     Text format    


    November 2015
  80. SERINO G, Pesce F, Sallustio F, De Palma G, et al
    In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy.
    Kidney Int. 2015 Nov 18. doi: 10.1038/ki.2015.
    PubMed     Text format     Abstract available


  81. RAMACHANDRAN R, Kumar V, Nada R, Jha V, et al
    Serial monitoring of anti-PLAR in initial PLAR-negative patients with primary membranous nephropathy.
    Kidney Int. 2015;88:1198-1199.
    PubMed     Text format    


  82. COUSER WG, Johnson RJ
    What is myeloperoxidase doing in ANCA-associated glomerulonephritis?
    Kidney Int. 2015;88:938-940.
    PubMed     Text format     Abstract available


    April 2015
  83. CROFT AP, Smith SW, Carr S, Youssouf S, et al
    Successful outcome of pregnancy in patients with anti-neutrophil cytoplasm antibody-associated small vessel vasculitis.
    Kidney Int. 2015;87:807-11.
    PubMed     Text format     Abstract available


    March 2015
  84. SCHREIBER A, Schindler R, Adcock Funk DM, Kahl A, et al
    The Case | A 48-year-old man with pulmonary-renal syndrome.
    Kidney Int. 2015;87:667-8.
    PubMed     Text format    


  85. SPINALE JM, Mariani LH, Kapoor S, Zhang J, et al
    A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease.
    Kidney Int. 2015;87:564-74.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: